NSE · SUPRIYA
Supriya Lifescience Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#660
of 5,072 stocks
▲ 311W
Peak #660 · 27 Sep 2026
Supriya Lifescience Limited, a midcap Healthcare business, remains firmly promoter-controlled, with promoters holding 68%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
7,929.38 Cr
P/E Ratio
37.92
P/B Ratio
6.62
ROE
17.46%
ROCE
22.42%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 189.75 Cr | 276.53 Cr | 206.44 Cr | 199.83 Cr |
| Net Profit | 24.04 Cr | 74.23 Cr | 49.68 Cr | 50.43 Cr |
| EPS | 2.99 | 9.22 | 6.17 | 6.27 |
| Operating Profit | 41.17 Cr | 92.60 Cr | 67.87 Cr | 68.73 Cr |
Shareholding pattern
Promoter
68.30%
Public
31.70%
Mutual fund holdings
₹82.24
Cr total
12
Schemes
7
Fund Houses
₹82.24 Cr
Total Exposure
Abakkus Mutual Fund₹42.89 Cr (52.2%)
ITI Mutual Fund₹19.80 Cr (24.1%)
Quantum Mutual Fund₹8.74 Cr (10.6%)
WhiteOak Capital Mutual Fund₹5.40 Cr (6.6%)
Motilal Oswal Mutual Fund₹5.38 Cr (6.5%)
Others₹0.04 Cr (0.1%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 04 Sep 2025 | Dividend | Dividend - Re 1 Per Share |
| 20 Sep 2024 | Dividend | Annual General Meeting/Dividend - Rs 0.80 Per Share |
| 15 Sep 2023 | Dividend | Annual General Meeting/Dividend - Re 0.60 Per Share |
| 01 Sep 2022 | Dividend | Annual General Meeting/Dividend - Re 0.60 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.